Books on the topic 'HIV (Viruses) Gene therapy'

To see the other types of publications on this topic, follow the link: HIV (Viruses) Gene therapy.

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'HIV (Viruses) Gene therapy.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Bauer, Gerhard, and Joseph S. Anderson. Gene Therapy for HIV. New York, NY: Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4939-0434-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Vos, Jean-Michel H., ed. Viruses in Human Gene Therapy. Dordrecht: Springer Netherlands, 1995. http://dx.doi.org/10.1007/978-94-011-0555-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Singwi, Sanjeev. HIV gene therapy using nucleases. Ottawa: National Library of Canada, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Smith, Clay. Gene Therapy for HIV Infection. Berlin, Heidelberg: Springer Berlin Heidelberg, 1998. http://dx.doi.org/10.1007/978-3-662-11821-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Hengge, Ulrich R. Immunotreatment and gene therapy of HIV infection. Bremen: Uni-Med, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Berkhout, Ben, Hildegund C. J. Ertl, and Marc S. Weinberg, eds. Gene Therapy for HIV and Chronic Infections. New York, NY: Springer New York, 2015. http://dx.doi.org/10.1007/978-1-4939-2432-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Virology, Conference on. HIV and other highly pathogenic viruses. San Diego: Academic Press, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Canada, Canada Health and Welfare. Therapy and management of CMV in patients with HIV infection/ by Susan M.King. Ottawa: Health and Welfare Canada, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Lombardi, Rocco Anthony. GAG and ENV trans-dominant mutants for use in ANTI-HIV-1 gene therapy. Ottawa: National Library of Canada, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Catalán, José. Psychological medicine of HIV infection. Oxford: Oxford University Press, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
11

Catalán, José. Psychological medicine of HIV infection. Oxford: Oxford University Press, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
12

Mindel, Adrian. AIDS: A pocket book of diagnosis and management. 2nd ed. London: Arnold, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
13

Brambilla, Riccardo. Viral vector approaches in neurobiology and brain diseases. New York: Humana Press, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
14

International Washington Spring Symposium (10th 1990 George Washington University). Advances in molecular biology and targeted treatment for AIDS. New York: Plenum Press, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
15

Tokyo Institute of Psychiatry. International Symposium. Cutting edge medicine and liaison psychiatry: Psychiatric problems of organ transplantation, cancer, HIV/AIDS, and genetic therapy : proceedings of the 13th Tokyo Institute of Psychiatry International Symposium held in Tokyo on 29-30 September 1998. Edited by Matsushita Masaaki 1937- and Fukunishi Isao. Amsterdam: Elsevier, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
16

Juelg, Boris, and Rajesh Gandhi. HIV Cure Strategies. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190493097.003.0006.

Full text
Abstract:
Although current antiretroviral therapy (ART) is highly effective at controlling HIV-1 replication, it does not eradicate or cure the infection. HIV-1 persists quiescently in cellular reservoirs, not detected by the immune system due to the lack of active viral replication; these reservoirs represent the major obstacle for cure approaches. Reversal of HIV-1 latency and induction of virus expression by a variety of interventions may render infected cells susceptible to immune recognition and active clearance. Strategies to boost immune responses via vaccination, immunomodulation, or gene therapy are being evaluated with the aim of achieving HIV-1 control without antiretroviral therapy, if not viral eradication.
APA, Harvard, Vancouver, ISO, and other styles
17

H, Vos Jean-Michel, ed. Viruses in human gene therapy. Durham, N.C: Carolina Academic Press, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
18

Naicker, Saraladevi, and Graham Paget. HIV and renal disease. Edited by Vivekanand Jha. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199592548.003.0187_update_001.

Full text
Abstract:
The human immunodeficiency virus (HIV) infection epidemic has particularly affected the poorest regions of the world. HIV can directly or indirectly affect different aspects of renal function, and results in a variable expression of kidney disease.Acute kidney injury (AKI) occurs in approximately 20% of hospitalized patients. The prevalence of chronic kidney disease (CKD) amongst HIV-infected patients is reported at 3.5–38% in different regions of the world. The complex interplay between the pheno- and/or genotypic variants of the virus, the genetic make-up of the host, and environmental factors determine the clinical manifestations of renal disease. The association of APOL1 gene variants G1 and G2 with the risk of focal segmental glomerulosclerosis explains the high frequency of HIV-associated nephropathy (HIVAN) in populations of black ethnicity.Anti-retroviral therapy (ART) is effective in preventing progression of HIVAN. Some of the drugs used in ART regimens are potentially nephrotoxic and require dose adjustment or even avoidance in CKD. Progression to end-stage renal disease (ESRD) in HIVAN has been reported to correlate with the extent of chronic damage quantified by renal biopsy.HIV-infected patients requiring dialysis, who are stable on ART, are achieving survival rates comparable to those of non-HIV dialysis populations. Similarly, HIV infection does not seem to adversely affect patient and graft survival rates after kidney transplantation, and there has been no increase in the prevalence of opportunistic infections in transplant recipients on effective ART.
APA, Harvard, Vancouver, ISO, and other styles
19

Gene therapy for HIV infection. Georgetown, Tex: R.G. Landes, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
20

Ian, Phillips M., ed. Gene therapy methods. San Diego, Calif: Academic Press, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
21

Berkhout, Ben, Hildegund C. J. Ertl, and Marc S. Weinberg. Gene Therapy for HIV and Chronic Infections. Springer, 2015.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
22

Sax, Paul E., Calvin J. Cohen, and Daniel R. Kuritzkes. HIV Essentials 2010. Jones & Bartlett Learning, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
23

Cid-Arregui, Angel. Viral Vectors: Basic Science and Gene Therapy. EATON PUBLISHING, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
24

Biloshytsky, Vadym, and Roman Cregg. Pioneering use of gene therapy for pain. Edited by Paul Farquhar-Smith, Pierre Beaulieu, and Sian Jagger. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198834359.003.0083.

Full text
Abstract:
The landmark paper discussed in this chapter is ‘Gene therapy for pain: Results of a Phase I clinical trial’, published by Fink et al. in 2011. In this study, the first of its kind, researchers studied the efficacy and safety of a modified herpes simplex virus (HSV) vector used to deliver PENK, which encodes proenkephalin, which is cleaved into the enkephalin peptides Met-enkephalin and Leu-enkephalin, which induce analgesia by acting on opioid receptors. The development of the HSV vector was based in part on results studies in which adenovirus, adeno-associated virus, or non-viral vectors were used to overexpress genes. Overexpression of a variety of large molecules leads to a reduction in pain-related behaviour in animals. Gene therapy in the treatment of chronic pain seems to offer a promising alternative to systemic or highly invasive therapies. However, additional research is needed to determine the safety, effectiveness, and cost-efficiency of this approach.
APA, Harvard, Vancouver, ISO, and other styles
25

(Editor), Jacqueline D. Reeves, and Cynthia A. Derdeyn (Editor), eds. Entry Inhibitors in HIV Therapy (Milestones in Drug Therapy) (Milestones in Drug Therapy). Birkhäuser Basel, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
26

A, Haseltine William, Wong-Staal Flossie, and Harvard AIDS Institute, eds. Genetic structure and regulation of HIV. New York: Raven Press, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
27

Bauer, Gerhard, and Joseph S. Anderson. Gene Therapy for HIV: From Inception to a Possible Cure. Springer, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
28

Robert, Franza B., Cullen Bryan, and Wong-Staal Flossie, eds. The Control of human retrovirus gene expression. Cold Spring Harbor, N.Y: Cold Spring Harbor Laboratory, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
29

1958-, Harrington Kevin J., Pandha Hardev, and Vile Richard G, eds. Viral therapy of cancer. Chichester, West Sussex, England: John Wiley & Sons, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
30

Harrington, K. J. Viral Therapy of Cancer. John Wiley & Sons, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
31

(Editor), P. R. Lowenstein, and L. W. Enquist (Editor), eds. Protocols for Gene Transfer in Neuroscience: Towards Gene Therapy of Neurological Disorders. John Wiley & Sons, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
32

R, Lowenstein P., and Enquist L. W, eds. Protocols for gene transfer in neuroscience: Towards gene therapy of neurological disorders. Chichester: J. Wiley & Sons, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
33

Factor, Phillip H. Gene Therapy for Acute and Acquired Diseases. Springer, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
34

Factor, Phillip H. Gene Therapy for Acute and Acquired Diseases. Springer, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
35

Emini, Emilio. The Human Immunodeficiency Virus: Biology, Immunology, and Therapy. Princeton University Press, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
36

The Human immunodeficiency virus: Biology, immunology, and therapy. Princeton, N.J: Princeton University Press, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
37

A, Machida Curtis, ed. Viral vectors for gene therapy: Methods and protocols. Totowa, N.J: Humana Press, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
38

A, Machida Curtis, ed. Viral vectors for gene therapy: Methods and protocols. Totowa, N.J: Humana Press, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
39

A, Machida Curtis, ed. Viral vectors for gene therapy: Methods and protocols. Totowa, New Jersey: Humana Press, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
40

Medina, Maria Fe C. Strategies for isolation and expression of ribozymes for use in HIV gene therapy. 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
41

(Editor), Michael G. Kaplitt, and Arthur D. Loewy (Editor), eds. Viral Vectors: Gene Therapy and Neuroscience Applications. Academic Press, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
42

G, Kaplitt Michael, and Loewy Arthur D, eds. Viral vectors: Gene therapy and neuroscience applications. San Diego: Academic Press, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
43

(Editor), Michael G. Kaplitt, and Arthur D. Loewy (Editor), eds. Viral Vectors: Gene Therapy and Neuroscience Applications. Academic Press, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
44

Viral Vectors: Gene Therapy and Neuroscience Applications. Academic Press, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
45

(Editor), Michael G. Kaplitt, and Arthur D. Loewy (Editor), eds. Viral Vectors: Gene Therapy and Neuroscience Applications. Academic Press, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
46

(Editor), Boro Dropulic, and Barrie Carter (Editor), eds. Concepts in Genetic Medicine. Wiley, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
47

Concepts in genetic medicine. Hoboken, N.J: John Wiley & Sons, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
48

Machida, Curtis A. Viral Vectors for Gene Therapy: Methods and Protocols (Methods in Molecular Medicine). Humana Press, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
49

Ramezani, Ali. Development and testing of mono- and multimeric hammerhead ribozymes for HIV-1 gene therapy. 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
50

G, Giraldo, ed. Development and applications of vaccines and gene therapy in AIDS. Basel: Karger, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography